Literature DB >> 17016156

A meta-analysis of quantitative EEG power associated with attention-deficit hyperactivity disorder.

Steven M Snyder1, James R Hall.   

Abstract

A meta-analysis was performed on quantitative EEG (QEEG) studies that evaluated attention-deficit hyperactivity disorder (ADHD) using the criteria of the DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 4th edition). The nine eligible studies (N = 1498) observed QEEG traits of a theta power increase and a beta power decrease, summarized in the theta/beta ratio with a pooled effect size of 3.08 (95% confidence interval, 2.90, 3.26) for ADHD versus controls (normal children, adolescents, and adults). By statistical extrapolation, an effect size of 3.08 predicts a sensitivity and specificity of 94%, which is similar to previous results 86% to 90% sensitivity and 94% to 98% specificity. It is important to note that the controlled group studies were often with retrospectively set limits, and that in practice the sensitivity and specificity results would likely be more modest. The literature search also uncovered 32 pre-DSM-IV studies of ADHD and EEG power, and 29 of the 32 studies demonstrated results consistent with the meta-analysis. The meta-analytic results are also supported by the observation that the theta/beta ratio trait follows age-related changes in ADHD symptom presentation (Pearson correlation coefficient, 0.996, P = 0.004). In conclusion, this meta-analysis supports that a theta/beta ratio increase is a commonly observed trait in ADHD relative to normal controls. Because it is known that the theta/beta ratio trait may arise with other conditions, a prospective study covering differential diagnosis would be required to determine generalizability to clinical applications. Standardization of the QEEG technique is also needed, specifically with control of mental state, drowsiness, and medication.

Entities:  

Mesh:

Year:  2006        PMID: 17016156     DOI: 10.1097/01.wnp.0000221363.12503.78

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  71 in total

1.  The cerebellum in emotion regulation: a repetitive transcranial magnetic stimulation study.

Authors:  Dennis J L G Schutter; Jack van Honk
Journal:  Cerebellum       Date:  2009-03       Impact factor: 3.847

Review 2.  Stimulant prescription cautions: addressing misuse, diversion and malingering.

Authors:  David L Rabiner
Journal:  Curr Psychiatry Rep       Date:  2013-07       Impact factor: 5.285

3.  EEG power spectral slope differs by ADHD status and stimulant medication exposure in early childhood.

Authors:  Madeline M Robertson; Sarah Furlong; Bradley Voytek; Thomas Donoghue; Charlotte A Boettiger; Margaret A Sheridan
Journal:  J Neurophysiol       Date:  2019-10-16       Impact factor: 2.714

Review 4.  Quantitative electroencephalography and attention-deficit/hyperactivity disorder: implications for clinical practice.

Authors:  Vincent J Monastra
Journal:  Curr Psychiatry Rep       Date:  2008-10       Impact factor: 5.285

5.  Gamma oscillations and schizophrenia.

Authors:  Sylvain Williams; Patricia Boksa
Journal:  J Psychiatry Neurosci       Date:  2010-03       Impact factor: 6.186

Review 6.  Deviations from the expectable environment in early childhood and emerging psychopathology.

Authors:  Kathryn L Humphreys; Charles H Zeanah
Journal:  Neuropsychopharmacology       Date:  2014-07-07       Impact factor: 7.853

7.  Physiologic artifacts in resting state oscillations in young children: methodological considerations for noisy data.

Authors:  Kevin McEvoy; Kyle Hasenstab; Damla Senturk; Andrew Sanders; Shafali S Jeste
Journal:  Brain Imaging Behav       Date:  2015-03       Impact factor: 3.978

Review 8.  Aberrant Modulation of Brain Oscillatory Activity and Attentional Impairment in Attention-Deficit/Hyperactivity Disorder.

Authors:  Agatha Lenartowicz; Ali Mazaheri; Ole Jensen; Sandra K Loo
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-10-06

Review 9.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Authors:  Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson
Journal:  BMC Psychiatry       Date:  2010-09-03       Impact factor: 3.630

10.  Cognitive and neurophysiological markers of ADHD persistence and remission.

Authors:  Celeste H M Cheung; Fruhling Rijsdijk; Gráinne McLoughlin; Daniel Brandeis; Tobias Banaschewski; Philip Asherson; Jonna Kuntsi
Journal:  Br J Psychiatry       Date:  2015-08-06       Impact factor: 9.319

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.